MENU
AKRO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Akero Therapeutics (AKRO) Ownership - Who owns Akero Therapeutics?

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs... Show more

Profile

Industry
N/A
Address
601 Gateway Boulevard
Phone
+1 650 487-6488
Employees
56
Web
https://www.akerotx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.85B
P/E Ratio
N/A
Total Cash
742.32M
Projected Growth
N/A
Total Debt
37.19M
Revenue
N/A
Risk (Beta)
-1.22
Dividend Yield
N/A
Total Cash/Share
9.28
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

AKRO
Capitalization
3.85B
P/E Ratio
N/A
Risk (Beta)
-1.22
Dividend Yield
N/A
Total Cash
742M
Total Cash/Share
9.28
Total Debt
37.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
1.03B
P/B Ratio
3.75
Cash Flow
N/A
Earnings
-3.81
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8K
Current Ratio
12.66
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-279.17M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-28.77
Shares Held By Institutions
6.16B
Shares Outstanding - Current
80M
Total Liabilities
83.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
72.969
View a ticker or compare two or three
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AKRO showed earnings on August 08, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a biotechnology company, which specializes in transformational treatments for non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
601 Gateway Boulevard
Phone
+1 650 487-6488
Employees
56
Web
https://www.akerotx.com